“Trump Administration Rule Forces Pharmacy Benefit Managers to Disclose Secret Drug Payment” — what this page in the network covers. A new federal rule from the Trump administration will compel pharmacy benefit managers (PBMs) to disclose fees and compensation details that have long been kept private. The rule targets the middlemen who negotiate drug prices between manufacturers, insurers, and pharmacies, aiming to bring transpar The rule targets the middlemen who negotiate drug prices between manufacturers, insurers, and pharmacies, aiming to bring transparency to a system that critics say inflates costs for patients and employers.
PBMs have faced scrutiny for retaining rebates and charging spread pricing, often without clear disclosure to plan sponsors or regulators. By requiring these entities to share payment data, the administration seeks to expose hidden revenue streams and give employers and government programs better leverage in negotiations. For the complete material, the listing points back to the source inside the network.